108 related articles for article (PubMed ID: 1988367)
1. Histological and urinary reactivity of monoclonal antibody 1BE12 in bladder carcinoma. Purification of the antigen from urine.
Pancino G; Toubert ME; Osinaga E; Chatelet F; Leroy M; Schlageter MH; Desroys du Roure F; Calvo F; Teillac P; Najean Y
Int J Cancer; 1991 Jan; 47(2):221-6. PubMed ID: 1988367
[TBL] [Abstract][Full Text] [Related]
2. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.
Pancino G; Charpin C; Osinaga E; Betaille B; Le Roy M; Calvo F; Roseto A
Cancer Res; 1990 Nov; 50(22):7333-42. PubMed ID: 2224861
[TBL] [Abstract][Full Text] [Related]
3. Characterization of mouse monoclonal antibody B1.4 reactive with human invasive bladder cancer and some other malignant tumors but not with normal urinary epithelium.
Saiki S; Kinouchi T; Kuroda M; Uenaka A; Nakayama E; Kotake T
Jpn J Cancer Res; 1994 Jul; 85(7):756-61. PubMed ID: 8071117
[TBL] [Abstract][Full Text] [Related]
4. Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors.
Cordon-Cardo C; Wartinger DD; Melamed MR; Fair W; Fradet Y
Am J Pathol; 1992 Feb; 140(2):375-85. PubMed ID: 1739131
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.
Huland E; Huland H; Meier T; Baricordi O; Fradet Y; Grossman HB; Hodges GM; Messing EM; Schmitz-Draeger BJ
J Urol; 1991 Dec; 146(6):1631-6. PubMed ID: 1719252
[TBL] [Abstract][Full Text] [Related]
6. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies raised against cell membrane components of human bladder tumor tissue recognizing subpopulations in normal urothelium.
Summerhayes IC; McIlhinney RA; Ponder BA; Shearer RJ; Pocock RD
J Natl Cancer Inst; 1985 Dec; 75(6):1025-38. PubMed ID: 2415743
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody against a tumor-associated sialoglycoprotein of superficial papillary bladder tumors and cervical condylomas.
Fradet Y; LaRue H; Parent-Vaugeois C; Bergeron A; Dufour C; Boucher L; Bernier L
Int J Cancer; 1990 Dec; 46(6):990-7. PubMed ID: 1701166
[TBL] [Abstract][Full Text] [Related]
9. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
[TBL] [Abstract][Full Text] [Related]
10. Increase in murine monoclonal-antibody-defined urinary antigens in patients with bladder cancer and benign urogenital disease.
Masuko T; Sugahara K; Kamiya T; Hashimoto Y
Int J Cancer; 1989 Oct; 44(4):582-8. PubMed ID: 2676868
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody (BL2-10D1) reacting with a bladder-cancer-associated antigen.
Longin A; Hijazi A; Berger-Dutrieux N; Escourrou G; Bouvier R; Richer G; Mironneau I; Fontanière B; Devonec M; Laurent JC
Int J Cancer; 1989 Feb; 43(2):183-9. PubMed ID: 2645218
[TBL] [Abstract][Full Text] [Related]
12. The monoclonal antibody BQ16 identifies the alpha 6 beta 4 integrin on bladder cancer.
Liebert M; Wedemeyer G; Stein JA; Washington RW; Van Waes C; Carey TE; Grossman HB
Hybridoma; 1993 Feb; 12(1):67-80. PubMed ID: 8454305
[TBL] [Abstract][Full Text] [Related]
13. Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells.
Bonner RB; Hemstreet GP; Fradet Y; Rao JY; Min KW; Hurst RE
Cancer; 1993 Oct; 72(8):2461-9. PubMed ID: 8402463
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies for characterization of the heterogeneity of normal and malignant transitional cells.
Arndt R; Dürkopf H; Huland H; Donn F; Loening T; Kalthoff H
J Urol; 1987 Apr; 137(4):758-63. PubMed ID: 3550155
[TBL] [Abstract][Full Text] [Related]
15. Detection of onco-fetal bladder antigen in urine of patients with transitional cell carcinoma.
Liu BC; Neuwirth H; Zhu LW; Stock LM; Dekernion JB; Fahey JL
J Urol; 1987 Jun; 137(6):1258-61. PubMed ID: 3295305
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody 486 P 3/12: a valuable bladder carcinoma marker for immunocytology.
Huland H; Arndt R; Huland E; Loening T; Steffens M
J Urol; 1987 Apr; 137(4):654-9. PubMed ID: 2435926
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the anti-bladder-cancer monoclonal antibody BLCA-8: identification of its antigen as a neutral glycolipid.
Kingsley EA; Carter TE; Barrow KD; Russell PJ
Cancer Immunol Immunother; 1995 Dec; 41(6):348-54. PubMed ID: 8635192
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4.
Pancino G; Osinaga E; Charpin C; Mistro D; Barque JP; Roseto A
Br J Cancer; 1991 Mar; 63(3):390-8. PubMed ID: 1706194
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of the urinary bladder carcinoma antigen ELISA test and multiparametric DNA/cytokeratin flow cytometry in urine voided samples from patients with bladder carcinoma.
Sánchez-Carbayo M; Ciudad J; Urrutia M; Navajo JA; Orfao A
Cancer; 2001 Dec; 92(11):2811-9. PubMed ID: 11753954
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.
Anagnostaki E; Skarlos D; Tamvakis N; Psaropoulou P; Blana E; Bamias A; Legaki S; Aravantinos G; Deliveliotis C; Dimopoulos K
Br J Cancer Suppl; 1990 Jul; 10():52-6. PubMed ID: 2200496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
